Back

Beta-blocker after acute coronary syndrome: is it time to individualize therapy?

11 April 2019 (17:45 - 18:00)
Organised by:
Congress Presentation Part of: Young Investigator Award 1 - Population science and public health Section Secondary Prevention EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Doctor Pedro Azevedo

Algarve University Hospital Center, Faro (Portugal)

5 More presentations in this session

Presentation thumbnail
Urinary ethyl glucuronide as measure of alcohol consumption and cardiovascular disease: a population-based cohort study
Ms I. van de Luitgaarden (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Body mass index and blood pressure as predictors of cardiomegaly-associated line-of-duty sudden cardiac death in US firefighters: a case-control study
Doctor M. Korre (Boston, US)
Abstract Slides Video
Presentation thumbnail
Epigenetic marker partially mediates the association between statin therapy and type 2 diabetes risk
Ms C. Ochoa-Rosales (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Greater cardiorespiratory fitness reduces atrial fibrillation incidence: a meta-analysis
Mr C. Verdicchio (Canberra, AU)
Abstract
Presentation thumbnail
Arterial age and early vascular aging, but not chronological age, are associated with faster thoracic aortic aneurysm growth
Doctor N. Santi (Ottawa, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award 1 - Population science and public health Section

The Event

Event poster

EuroPrevent 2019

11 April 2019 17:45 CET
You may be interested in
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
thumbnail
Congress Presentation
Optimal medical therapy for primary prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources